Abstract. Many studies have been performed to assess correlations between measures derived from dose-volume histograms and late rectal toxicities for radiotherapy of prostate cancer. The purpose of this study was to quantify correlations between measures describing the shape and location of the dose distribution and different outcomes. The dose to the rectal wall was projected on a two-dimensional map. In order to characterize the dose distribution, its centre of mass, longitudinal and lateral extent, and eccentricity were calculated at different dose levels. Furthermore, the dosesurface histogram (DSH) was determined. Correlations between these measures and 7 clinically-relevant rectal-toxicity endpoints were quantified by maximally selected standardised Wilcoxon rank statistics. The analysis was performed using data from the RT01 prostate radiotherapy trial. For some endpoints the shape of the dose distribution is more strongly correlated with the outcome than simple DSHs. Rectal bleeding was most strongly correlated with lateral extent of the dose distribution. For loose stools the strongest correlations were found for longitudinal extent; proctitis was most strongly correlated with DSH. For the other endpoints no statistically-significant correlations could be found. The strengths of the correlations between the shape of the dose distribution and
outcome differed considerably between the different endpoints. Due to these significant correlations, it is desirable to use shape-based tools in order to assess the quality of a dose distribution.
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Introduction
Many attempts have been made to model relationships between the dose delivered to an organ at risk and radiation-induced complications. In order to assess correlations between dosimetric parameters and outcome, the three-dimensional dose distribution is typically summarized in a dose-volume histogram (DVH) or a dose-surface histogram (DSH), which is then reduced to one single number. Usually the dose delivered to an organ is described by a measure such as the mean dose, the volume receiving more than a threshold dose d (V d ) or the equivalent uniform dose (EUD). Univariate or multivariate statistical analysis can be used in order to find correlations between this summary measure and late complications. Many authors have investigated the occurrence of gastrointestinal toxicity after radiotherapy treatment of prostate carcinoma (Schultheiss et al. 1995 , Boersma et al. 1998 , Jackson et al. 2001 , Wachter et al. 2001 , Fiorino et al. 2003 , and references therein). These investigations have resulted in many, partially contradictory, results. For example, some groups identified the parts of the rectum irradiated with doses greater than 60 Gy as being responsible for rectal bleeding (Benk et al. 1993 , Storey et al. 2000 , while others suggest that this is the case for lower doses in the order of 35 Gy (Skwarchuk et al. 2000) . Some studies suggest that there are no better predictive models for late rectal bleeding than those based on the mean dose to the rectum (Tucker et al. 2004 ). In contrast, other studies conclude that there is no significant correlation at all between the mean dose and rectal bleeding (Söhn et al. 2007 ). Several authors , IMRTC Working Group 2001 have pointed out the problems that occur using DVH-based methods to model the dose response for late rectal toxicity. First, there are strong correlations between different summary measures such as V 30 and V 60 so that it is hard to single out the summary measure with the strongest correlation. When quantifying correlations between these measures and outcomes, multiple tests are performed. As it is difficult to perform an appropriate multiple-testing correction, often no correction is performed at all so that significance levels are over-estimated . Second, all spatial information is generally lost when using DVHs or DSHs. Gulliford et al. (2004) used all available information from a DVH as an input for a neural network, which was trained to predict rectal toxicity and biomedical control. Tucker et al. (2006) have suggested the use of cluster models which are based on the hypothesis that the complication probability depends on the size of clusters of damaged tissue. More recently, Gianolini et al. (2008) and Munbodh et al. (2007) suggested the extraction of spatial features from dose-surface-maps (DSMs) and testing correlations with rectal toxicity. In a previous analysis some of the authors investigated the predictive power of DSMs by comparing the performance of a neural network classifier based on DSMs to the performance of a similar classifier using DSHinformation only (Buettner et al. 2009 ). However, no detailed analysis assessing the type of relationships between spatial features and outcomes has been performed. The purpose of this work is to identify geometrical features which describe the spatial distribution of the dose to the rectal wall and assess associations with reported late rectal toxicity.
Materials and Methods

Patient Cohort
This analysis was based on data from the MRC RT01 multicentre randomized controlled trial (ISRCTN 47772397) . In this trial, 843 men with localised prostate cancer were treated with 3D conformal radiotherapy, 421 with a prescribed standard dose of 64 Gy, 422 with an escalated dose of 74 Gy; the dose per fraction was 2 Gy for all patients and all patients had a minimum follow-up of two years. The rectum was outlined from the anus taken at the level of the ischial tuberosities or 1 cm below the planning target volume, whichever was more inferior to the rectosigmoid junction. In order to deliver the initial 64 Gy the centers could choose to use either a 3-field or a 4-field technique; patients who were randomized to 74 Gy received the 10 Gy boost to the prostate using either 4 or 6 fields. Further details about the implementation and first results of the trial can be found in Sydes et al. (2004) and Dearnaley et al. (2007) respectively. Planning data as well as comprehensive data on late toxicity were available for a subgroup of 388 patients (Gulliford et al. in press) . Previous analyses of these data have been performed with a focus on the relations between dose, volume and late effects on sexual function (Mangar et al. 2006) as well as a variety of late rectal toxicities (Gulliford et al. in press) . In the present analysis, dosimetric effects of seven clinically-relevant rectal toxicity endpoints (including patient and clinician reported outcomes) were considered separately (table 1) . Only patients who were free of the respective symptom before treatment were considered. Toxicity was defined as the highest grade reported during the follow-up. In the conventional DVH-analysis of the original trial a three-grade scheme was used for all toxicities to bring together the different grading schemes (table 1, (Gulliford et al. in press) ). This common grading scheme was also used in this analysis. The number of patients who reported each grade of toxicity is listed in table 2.
Characterization of the spatial distribution
The basis for the investigations presented in this study was a set of dose-surface maps (DSMs) of the rectum. These DSMs reflect the dose delivered to the surface of the rectal wall and are a well-known tool for analyzing radiation-induced rectal toxicity as well as organ motion (Sanchez-Nieto et al. 2001 , Munbodh et al. 2008 . Different algorithms to generate DSMs from the 3D dose distribution in the rectum exist (Sanchez-Nieto et al. 2001 , Munbodh et al. 2008 . The DSMs were constructed by virtually unfolding the rectum in a slice-wise manner following the methods reported in , Sanchez-Nieto et al. 2001 , Booth 2002 ). This method has been successfully used for analyzing the shape of rectal dose distributions (Gianolini et al. 2008 ) and results in intuitively interpretable maps. At every CT slice the contour was cut at its posterior-most location and the dose at 21 points, which were equally spaced along the contour, was determined by interpolation. This number of points was chosen as it corresponded to the resolution of the dose calculation grids used in the RT01 study. In order to facilitate inter-patient comparisons, these maps were normalized in the longitudinal direction by interpolation to maps of 21x21 pixels as the rectum had been outlined typically over a length of 21 slices of 0.5 cm. This was implemented using the in-house software "Guiness" (Mangar et al. 2006) . In order to characterize the spatial distribution of the dose with a limited number of features, each DSM was next described as a set of binary images. Let f (x, y), (x, y) ∈ {1, 2, . . . , 21} × {1, 2, . . . , 21} be the original DSM. Then 35 binary images f b corresponding to 35 different dose levels were generated by thresholding at different values α [Gy], α ∈ {5, 7, . . . , 73}:
This ensured a complete sampling across the full range of dose levels occurring in the study. In order to extract features from the stacks of binary images, all 1-valued pixels were grouped into a set of connected regions (clusters). An exact definition of a connected region is given in appendix A. Typically, the anterior part of the rectum, which is adjacent to the prostate, receives the highest dose, resulting in only one hot spot around which the dose decreases gradually. This explains why only one big cluster occurred in the binary images for most patients. Consequently, at every dose level the dose distributions were characterized using the following measures:
• DSH. The number of 1-valued pixels divided by the total number of pixels in the DSM (441 pixels). This corresponds to the proportion of the rectal wall, which received a dose greater than a respective dose level and can be interpreted as the bins of a cumulative DSH.
• Longitudinal position. The longitudinal (superior-inferior) position of the largest cluster was determined by calculating the longitudinal component of its centre of mass. It was measured in pixels from the bottom of the DSM.
• Shape. An ellipse with the same second moment as the cluster was fitted around it. The longitudinal and lateral extent of the largest clusters were quantified by projecting the axes of the ellipse to the main axes of the DSMs. The shape was described by the eccentricity of the ellipse. Figure 2 . In order to quantify the lateral and longitudinal extent of the dose distribution, an ellipse is fitted around it and its principal axes are projected to the main axes of the DSM. A binary image with α = 57Gy is shown; pixels receiving doses greater or equal to 57 Gy are displayed in white, pixels receiving less than 57 Gy are displayed in grey. The projections of the principal axes of the ellipse are shown in red.
Figures 1(a) and 1(b) represent a normalized DSM of a typical patient and the corresponding set of binary images. The extraction of the morphological features is illustrated in figure 2.
Assessing the associations between dosimetric factors and outcomes
In order to assess the relationships between the suggested measures and the outcomes, it is desirable to not only quantify the degree of association (i.e. p-value) but also the type of relationship. We chose to use a simple cut-point model as this gives intuitive insight into the type of relationship between dosimetric variables and outcomes and is used for treatment-planning purposes in form of dose-volume constraints. Therefore all possible unique partitions of the data generated by thresholding all variables were considered and a joint linear test statistic T was evaluated.
Let X i denote the feature-vector consisting of the 175 dosimetric features presented in the previous section, being 35 lateral extents, 35 longitudinal extents, 35 eccentricities and 35 longitudinal positions at 35 dose levels as well as 35 bins of the DSH. Let X ik be the kth feature and Y i the outcome under consideration for all baseline-free patients (i ∈ {1, . . . , N } with N being the number of baseline-free patients for the endpoint under consideration).
Then we would like to test the null-hypothesis
of independence of Y and X against shift alternatives, that is variations of the distribution of the outcome D(Y) between different groups of patients. These groups correspond to all unique partitions induced by all possible cut-points in each feature. The jth partition corresponding to a fixed cut-point ξ in the range of the kth feature X 1k . . . X N k can be described as g j (X i ) = I(X ik ≤ ξ), with I being the indicator function. In order to evaluate how well the cut-points describe the relationship between outcomes and dosimetric features a joint linear test statistic T ∈ R q with q being the number of unique partitions, was defined. The outcome Y i is an ordered variable with
T denote the rank vector of Y. Then, as reported by Lausen & Schumacher (1992) , a suitable test-statistic for partition j can be defined as
T j is the Wilcoxon rank sum statistic for the jth split of the patient cohort into 2 groups induced by ξ. In order to be able to compare the test statistics for the different partitions, T was standardized by its mean µ and variance
. Thus, the greater T , the greater the association between a specific cut-point and the outcome. A permutation approach was used to calculate the expectation µ and variance V (see appendix B). The randomization of the patients into the 64 Gy and the 74 Gy arm of the trial was taken into account by only allowing permutations within each arm.
In order to determine the significance of the different cut-points, the distribution of T has to be determined. Strasser & Weber (1999) showed that the distribution of the multivariate linear statistic T tends to a multivariate normal distribution with mean µ and variance V . However, due to the large number of cutpoints in this problem the calculation of this asymptotic distribution is not computationally feasible. Therefore Monte Carlo methods were used to determine p-values. T was calculated for 10000 block-wise permutations of Y and the p-values were calculated as proportion of permuted statistics that exceeded the observed statistic. In order to correct for multiple testing the free step-down resampling algorithm (Westfall & Young 1993) was applied, taking advantage of the dependence structure between the cut-points.
The analysis was performed using the environment for statistical computing R (R Development Core Team 2007) and the package for conditional interference procedures "Coin" (Hothorn et al. 2006 ).
Results
The statistical analysis of correlations between DSH and rectal bleeding indicates that a significant dose-surface response exists at doses ≥51 Gy. That is, a larger portion of the rectal wall irradiated at this dose level results in a higher complication probability. The strongest significant correlation with a p-value of 0.03 was found for those patients where more than 37.4% of the DSM received at least 51 Gy. In figure 3 the greatest T (T max ) is displayed for each variable. In all figures test statistics with a p-value less than 0.05 are displayed in red and are separated by a horizontal line.
Significant correlations (p < 0.05) were found for lateral extent at 8 dose levels between 39 Gy and 61 Gy, with the strongest correlation at 61 Gy (p<0.001) for the lateral extent of the dose distribution exceeding 59.1% of the circumference of the rectum (figure 4).
In contrast to rectal bleeding, low doses were found to be significantly correlated to occurrence of loose stools (figures 3 and 5). For DSHs significant correlations (p<0.05) were found for dose levels between 21 Gy and 27 Gy with the strongest association at 23 Gy (p=0.03). Associations with p<0.05 were found for longitudinal extent and eccentricity at different dose levels between 21 Gy and 33 Gy. The strongest correlation (p=0.002) was found for the longitudinal extent of the dose distribution at 23 Gy exceeding 109.2% of the length of the rectum. Due to the fitting of the ellipse longitudinal extents of up to 24.25 pixels, corresponding to 115.5% of the length of the rectum, were found. As the algorithm used to fit the ellipse to the largest cluster is not constraint to the size of the DSM, it will result in ellipses exceeding the dimensions of the DSM if the height of the respective cluster is close to the height of the DSM. This "extrapolation" is not only a mathematical construct, but has a physical interpretation as dose is also delivered to parts of the gastro-intestinal tract superior to the rectum.
For proctitis a significant correlation could be found between the lateral extent of doses ≥ 61 Gy exceeding 55% of the circumference of the rectum. The strongest association between proctitis and DSH occurred at doses ≥ 59 Gy with p = 0.13. In Figure 5. T max for lateral extent, longitudinal extent and eccentricity for loose stools. Lateral extent is represented by circles, longitudinal extent by bullets and eccentricity by crosses. Eccentricity was the only measure where the value of (T−µ) corresponding to the respective T max was less than 0.
figure 6, T max of the measures with the strongest associations, being DSH, lateral extent and longitudinal extent are illustrated. No significant correlations could be found between the dosimetric variables and stool frequency, rectal urgency, subjective sphincter control and sphincter management respectively. The strongest associations between the dosimetric variables and each of these endpoints as well as the respective p-values are listed in table 3. 
Discussion
It has been shown that the proposed spatial features correlate with a number of late complications in different ways. Although the DSH proved to be important, significantly stronger correlations could be found for the lateral extent of the dose distribution. This indicates that the fraction of the circumference of the rectal wall irradiated at high doses is specifically important. For loose stools the strongest correlations were found for longitudinal extent. However, eccentricity proved to be the measure with the strongest significant correlation for 25 Gy (p=0.02) and an association between the lateral extent and loose stools with p=0.056 could be found at 57 Gy.
These findings indicate that for loose stools different aspects of the dose distribution are relevant at different dose levels. While the longitudinal extent is most relevant at medium and low doses, the lateral extent is important for higher doses. For 25 Gy it is beneficial to have an eccentricically shaped dose distribution. The optimal cutpoint of the longitudinal extent exceeding 100% of the rectum length indicates that it can be beneficial to avoid also low doses to the gastrointestinal tract superior to the rectum. It has been shown that dose can effect small bowel motility leading to bacterial overgrowth and radiotherapy-induced diarrhoea (Andreyev 2007) . The fact that a high eccentricity is correlated with a decreased risk of loose stools leaves room for interpretation. It was proposed that one recovery mechanism involves the migration of non-damaged cells into the damaged area (Partridge 2008) . Experiments on mice gave evidence that recovery of damaged epithelial cells is related to cell migration (van Luijk et al. 2005) . Also, Hosoya et al. (2008) reported a non-local recovery mechanism, acting from non-irradiated tissue to irradiated tissue. Thus, it is preferable to have a shape with a high perimeter-to-surface ratio, which is reflected in the eccentricity, because that means that there is relatively more space for the non-damaged cells to migrate into the area with damaged cells.
When interpreting the results it is important to note that they are based on a statistical analysis of the data from a specific trial. Thus, the assessment of relationships between dose distribution and outcomes is performed within the space of dose distributions spanned by the treatment plans realized in the trial. Although one might intuitively expect significant correlations between very high doses and rectal bleeding, one result of the analysis was, for example, that there is no statistically significant correlation between the 71 Gy bin of the DSH and rectal bleeding. The proportion of the rectal wall of a patient with a prescribed dose of 74 Gy which receives at least 71 Gy lies in a range determined by the plans realized in the RT01 trial. Thus, the conclusion that even a substantial increase of the relative area of the rectal wall receiving doses of at least 71 Gy does not significantly increase the likelihood of the patient to report rectal bleeding is only valid for treatment plans similar to those realized in the RT01 trial. It should also be noted that the effect of the prescribed dose was considered by using blockwise calculations so that the results are valid for patients with a fixed prescribed dose only. However, the data was collected from a large-scale international multi-centre trial with no constraints on the dose to the rectum. Also, the centres could choose to treat the patients using 4-field or 3-field plans as well as whether to use multi-leaf-collimators or blocks to deliver the dose. This resulted in a relatively high variability of treatment plans, covering a very wide range of the treatment plans potentially delivered in clinical practice. Consequently, the corresponding dose distributions can be considered representative for 3D conformal prostate radiotherapy with a prescribed dose of 64 Gy or 74 Gy and the results gained from their analysis can be regarded as generally valid for this type of treatment.
Previous studies on dose-effect relations for rectal toxicities have investigated mainly the occurrence of rectal bleeding and were based on volumetric information in form of DVHs and DSHs. As the present study focuses on the evaluation of spatial features and assesses a variety of endpoints, it is difficult to compare results directly. Also, differences in radiotherapy-technique, volume definition and method of scoring complicate these comparisons. Most of the literature focuses on dose levels close to the prescription dose (≥ 60 Gy) (Boersma et al. 1998 , Fiorino et al. 2003 , Jackson et al. 2001 , Wachter et al. 2001 , Tucker et al. 2004 , Storey et al. 2000 . However, more recently, also correlations between volumes receiving lower doses between 30 Gy and 60 Gy and late rectal toxicities were reported (Peeters et al. 2006 , Vargas et al. 2005 , Greco et al. 2003 , Akimoto et al. 2004 . The significant correlations between DSH and rectal bleeding for doses between 40 Gy and 60 Gy found in this study are in agreement with these studies. Gulliford et al. (in press ) assessed correlations between a variety of rectal toxicities and DVH-parameters using data from the RT01 study and reported evidence for the importance of not only considering high doses close to the prescription dose for minimising the risk of late rectal toxicities.
In this study we exclusively used the physical dose as our explanatory variable. It is important to note, that other factors such as smoking, age, diabetes, neo-adjuvant androgen deprivation, previous abdominal/pelvic surgery and a genetic dispositions to a high/low radiosensitivity can impact the incidence of late rectal toxicity after radiotherapy (Skwarchuk et al. 2000 , Sanguineti et al. 2002 . These confounding factors could explain the relatively weak associations between dosimetric variables and rectal urgency, sphincter control and stool frequency. The high p-values for sphincter control are also related to the low incidence rate. The dose distribution was determined from a snapshot of the patient's anatomy at the time of the planning scan. Due to motion and uncertainties in the position of the rectum during the course of treatment, dose patterns change every day so that the actual dose delivered to the rectal wall might differ from the one calculated based on the planning CT. Fenwick (2001) assessed the influence of setup-errors and rectal wall movement on NTCP models and concluded that these uncertainties have only a slight impact on fits of NTCP models. However, these conclusions were based on a small number of patients treated with conventional or conformal radiotherapy. We also acknowledge that uncertainties due to motion are likely to have a bigger impact on NTCP models based on geometric features than on DSH-based models. Thus, in order to minimise motioninduced uncertainties, it is desirable to perform subsequent CT scans during the course of treatment instead of only one planning scan and take the additional information into account when modelling complications. However, that was not possible in this study as data from the RT01 trial was used retrospectively and patients entering that trial only had a single CT scan. It is acknowledged that there exist different algorithms to generate DSMs from the 3D dose distribution in the rectum (Sanchez-Nieto et al. 2001 , Munbodh et al. 2008 , so that the same dose distribution can result in different maps. However, to date there is no consensus to which algorithm best describes the dose delivered to the rectal wall as all of them suffer from different shortcomings. We chose to apply the slice-wise unfolding techinque as it has been used successfully for analysing the shape of rectal surface dose distributions (Gianolini et al. 2008 , Buettner et al. 2009 ) and results in intuitively interpretable maps as the rectal wall is displayed in the same frame of reference as the CT scan. Also, it has been stated that the use of a different technique such as weighting the surface according to the vertical angle of the rectum at the respective slice does only result in small changes (Booth 2002 ) and thus is a considerably smaller source of uncertainty than the uncertainty due to motion of the rectum. Another source of error is the choice of the grading scheme, as this can affect the magnitude of association between measure and outcome (van der Laan et al. 2008) .
Conclusion
We conclude that late complications in the rectum are not only related to DSHs and measures derived from these quantities, but also to the shape of the dose distribution. We have identified measures describing these characteristics and have quantified the strength of the correlations. The type of dose-relationships differed considerably between different endpoints. We found that the lateral extent of the dose distribution was considerably more strongly correlated to rectal bleeding than all other measures, including the DSH. The dosimetric measure with the strongest statistically significant correlation to loose stools and proctitis were longitudinal extent and DSHs respectively. No significant correlations to the dose distribution were found for sphincter control (subjective and management), stool frequency and rectal urgency. We therefore suggest application of shape-based tools in the treatment planning process additionally to DVH-based tools as this may enable a more fully assessment of the quality of dose distributions.
In order to be able to define a connected region, the concepts of connectivity and neighbourhood are needed.
Definition 1 For a pixel p = (x, y) the 4-neighbourhood is defined to be the set of pixels N 4 = {(x − 1, y), (x + 1, y), (x, y − 1), (x, y + 1)}.
Definition 2 A connecting path between two pixels p 1 = (x 1 , y 1 ) and p n = (x n , y n ) is a sequence of pixels (p i ) n i=1 such that for all p i = (x i , y i ) and p i+1 = (x i+1 , y i+1 ) with 1 ≤ i ≤ n − 1, p i ∈ N 4 (x i+1 , y i+1 ).
Definition 3 A connected region is a set of pixels such that there is at least one connecting path for each pair of pixels in this set.
Appendix B. Expectation and variance of T
Expectation µ = E(T|S) and variance V = V(T|S) of T under the null hypothesis of independence given all permutations S of outcomes Y i can be calculated as follows (Hájek et al. 1999) :
with g(X i ) ∈ R q being the q-dimensional vector coding all q partitions and • being the element-wise Hadamard product. Permutations were performed bock-wise for each arm of the trail. Thus, the expectation and variance were calculated separately for the patients in each arm of the trial. The expectation µ and variance V of T were determined as the sum over both separately calculated expectations and variances (Hothorn & Zeileis 2008) .
